喵ID:1tiPAa免责声明

Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes.

基本信息

DOI:
10.1016/j.neubiorev.2009.06.005
发表时间:
2010-04
影响因子:
8.2
通讯作者:
Meyer-Lindenberg, Andreas
中科院分区:
医学1区
文献类型:
Journal Article;Review
作者: Tost, Heike;Alam, Tajvar;Meyer-Lindenberg, Andreas研究方向: Behavioral Sciences;Neurosciences & NeurologyMeSH主题词: --
来源链接:pubmed详情页地址

文献摘要

Schizophrenia is a chronic, severe, and disabling brain disorder arising from the adverse interaction of predisposing risk genes and environmental factors. The psychopathology is characterized by a wide array of disturbing cognitive, emotional, and behavioral symptoms that interfere with the individual's capacity to function in society. Contemporary pathophysiological models assume that psychotic symptoms are triggered by a dysregulation of dopaminergic activity in the brain, a theory that is tightly linked to the serendipitous discovery of the first effective antipsychotic agents in the early 1950s. In recent years, the availability of modern neuroimaging techniques has significantly expanded our understanding of the key mediator circuits that bridge the gap between genetic susceptibility and clinical phenotype. This paper discusses the pathophysiological concepts, molecular mechanisms and neuroimaging evidence that link psychosis to disturbances in dopamine neurotransmission.
精神分裂症是一种慢性、严重且致残的脑部疾病,由易感风险基因和环境因素的不良相互作用引起。其精神病理学特征是存在大量令人困扰的认知、情感和行为症状,这些症状干扰个体在社会中发挥功能的能力。当代病理生理学模型假定,精神病性症状是由大脑中多巴胺能活动的失调所引发,这一理论与20世纪50年代初偶然发现的第一种有效的抗精神病药物密切相关。近年来,现代神经影像学技术的应用极大地拓展了我们对关键介导回路的理解,这些回路在遗传易感性和临床表型之间架起了桥梁。本文讨论了将精神病与多巴胺神经传递紊乱相关联的病理生理学概念、分子机制和神经影像学证据。
参考文献(131)
被引文献(107)
Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia
DOI:
10.1038/ng1296
发表时间:
2004-02-01
期刊:
NATURE GENETICS
影响因子:
30.8
作者:
Emamian, ES;Hall, D;Gogos, JA
通讯作者:
Gogos, JA
Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia
DOI:
10.1073/pnas.111134598
发表时间:
2001-06-05
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
Egan, MF;Goldberg, TE;Weinberger, DR
通讯作者:
Weinberger, DR
STEREOSELECTIVE BINDING OF 11C-RACLOPRIDE IN LIVING HUMAN-BRAIN - A SEARCH FOR EXTRASTRIATAL CENTRAL D2-DOPAMINE RECEPTORS BY PET
DOI:
10.1007/bf00212840
发表时间:
1988-01-01
期刊:
PSYCHOPHARMACOLOGY
影响因子:
3.4
作者:
FARDE, L;PAULI, S;STONEELANDER, S
通讯作者:
STONEELANDER, S
Schizophrenia: From dopamine to glutamate and back
DOI:
10.2174/0929867043456034
发表时间:
2004-02-01
期刊:
CURRENT MEDICINAL CHEMISTRY
影响因子:
4.1
作者:
Carlsson, ML;Carlsson, A;Nilsson, M
通讯作者:
Nilsson, M
Increased baseline occupancy of D2 receptors by dopamine in schizophrenia
DOI:
10.1073/pnas.97.14.8104
发表时间:
2000-07-05
期刊:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子:
11.1
作者:
Abi-Dargham, A;Rodenhiser, J;Laruelle, M
通讯作者:
Laruelle, M

数据更新时间:{{ references.updateTime }}

关联基金

Characterization of Genetic Mechanisms Contributing to Neuropsychiatric Disorder
批准号:
8556974
批准年份:
资助金额:
301.62
项目类别:
Meyer-Lindenberg, Andreas
通讯地址:
NIMH, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program, NIH,DHHS, Bethesda, MD 20892 USA
所属机构:
NIMHnNational Institutes of Health (NIH) - USAnNIH National Institute of Mental Health (NIMH)
电子邮件地址:
--
通讯地址历史:
Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, D-68159 Mannheim, Germany
所属机构
Cent Inst Mental Hlth
Central Institute of Mental Health
NIMH, Unit Syst Neurosci Psychiat, NIH, DHHS, Bethesda, MD 20892 USA
所属机构
NIMH
National Institutes of Health (NIH) - USA
NIH National Institute of Mental Health (NIMH)
NIMH, Neuroimaging Core Facil, NIH, DHHS, Bethesda, MD 20892 USA
所属机构
NIMH
National Institutes of Health (NIH) - USA
NIH National Institute of Mental Health (NIMH)
免责声明免责声明
1、猫眼课题宝专注于为科研工作者提供省时、高效的文献资源检索和预览服务;
2、网站中的文献信息均来自公开、合规、透明的互联网文献查询网站,可以通过页面中的“来源链接”跳转数据网站。
3、在猫眼课题宝点击“求助全文”按钮,发布文献应助需求时求助者需要支付50喵币作为应助成功后的答谢给应助者,发送到用助者账户中。若文献求助失败支付的50喵币将退还至求助者账户中。所支付的喵币仅作为答谢,而不是作为文献的“购买”费用,平台也不从中收取任何费用,
4、特别提醒用户通过求助获得的文献原文仅用户个人学习使用,不得用于商业用途,否则一切风险由用户本人承担;
5、本平台尊重知识产权,如果权利所有者认为平台内容侵犯了其合法权益,可以通过本平台提供的版权投诉渠道提出投诉。一经核实,我们将立即采取措施删除/下架/断链等措施。
我已知晓